Emerging Biopharma

Dedicated to your success

Win with a team dedicated to advancing your innovation, backed by the power of IQVIA. Maximize your asset’s probability of success in a complex, competitive environment with comprehensive solutions that intelligently connect best-in-class insights, technology, and expertise.
Video
Start small, dream big, succeed now

Develop and execute a winning asset launch strategy

For emerging biopharma and biotech companies to excel in today’s challenging environment, it’s critical to leverage a deep understanding of the patient profile and market dynamics throughout the journey from clinical to commercial. IQVIA Asset Maximizer is a comprehensive suite of solutions, delivered by experts dedicated to you, to help your breakthroughs get to patients, faster.

Asset success starts early for pharmaceutical companies with a need to ensure clinical trial design considers endpoints that demonstrate value to regulators, payers, prescribers, and the patient. Communicating that value requires an adaptable, omnichannel approach to activate and engage all stakeholders at launch and throughout the product lifecycle. Work with IQVIA, the global leader in clinical development, Real World Evidence, and the commercialization of new treatments to deliver a winning asset at launch and beyond.

ON-DEMAND WEBINAR

A Strategy for Progress: Bridging Data Silos for Emerging BioPharma

Don't let your organizations fragmented data be the reason for missed opportunities. Build a foundation of reliable data to ensure business decisions are made effectively and consistently.

Watch this session and learn how EBPs can effectively and affordably harness the robust matching capabilities of IQVIA Data Bridging.

IQVIA Connected Intelligence

Connecting people, intelligence, and innovation

IQVIA creates the connections for clinical and commercial customers to bring therapies to market and to the patients who need them. 

Contact Us